Thorne HealthTech, Inc. (THRN) is an innovative wellness company mainly focusing on providing solutions and personalized approach to the consumers. The company offers various health testing services for sleep, gut health, weight management, biological age and stress along with the development of nutritional supplements. One of the vertically integrated brand of the company is Onegevity that provides products and services to improve and maintain the heath of a person over time.
The price of THRN stock during the regular trading session of December 14, 2021 was $6.17. At the last check, in the market session of December 15, 2021, the stock was up by 5.35% to $6.30.
Events and Happenings
On December 14, 2021, THRN announced a new collaboration with professional cycling team, Human Powered Health (HPH), in which THRN will serve as their formal Personalized Health Solutions Partner. The partnership will equip the elite athletes of HPH with company’s health testing and nutritional supplement facilities which will be used to gear up their performance. The company will provide NSF Certified for Sport nutritional supplements to the athletes. The company’s team and technology deliver a custom plan to clients for eating, exercising and which supplement to take.
On November 22, 2021, THRN announced that Paul Jacobsen, Chief Executive Officer of Throne HelathTech will represent the company at the Evercore ISI 4th Annual HealthCONx Conference on Thursday, December 2, 2021.
On November 10, 2021, THRN announced its financial and operational results for the third quarter ended September 30, 2021. Some of the key financial highlights are as follows.
For the third quarter 2020, net income was $4.2 million, as opposed to net income of $1.0 million for the same period of 2021.
Loss per Share
The basic earning (loss) per share for the common stockholders for Q3 2021 was $0.02 while the diluted earning (loss) for the same period of 2021 was $0.01.
The stock of THRN saw a significant decline of 37.9% from the past month apparently due to uncertain reasons. As the company started a new collaboration with HPH, the analysts are confident that the price of the stock may surge in the coming days.